NO20010195L - Fremgangsmåte for behandling - Google Patents

Fremgangsmåte for behandling

Info

Publication number: NO20010195L
Authority: NO; Norway
Prior art keywords: treatment; alpha; methoxyimino; psychosis; azabicyclo
Prior art date: 1998-07-15

Application number

NO20010195A

Other languages

English (en)

Norwegian (no)

Other versions

NO20010195D0 (no

Inventor

Eve Naomi Cedar

James P Mccafferty

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-15

Filing date

2001-01-12

Publication date

2001-01-12

2001-01-12 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2001-01-12 Publication of NO20010195D0 publication Critical patent/NO20010195D0/no

2001-01-12 Publication of NO20010195L publication Critical patent/NO20010195L/no

Links

WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract 3
208000028017 Psychotic disease Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Chemical Treatment Of Metals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Liquid Crystal (AREA)
Liquid Crystal Substances (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

NO20010195A 1998-07-15 2001-01-12 Fremgangsmåte for behandling NO20010195L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815383.6A GB9815383D0 (en)	1998-07-15	1998-07-15	Novel method of treatment
PCT/US1999/016002 WO2000003717A1 (en)	1998-07-15	1999-07-15	Method of treatment

Publications (2)

Publication Number	Publication Date
NO20010195D0 NO20010195D0 (no)	2001-01-12
NO20010195L true NO20010195L (no)	2001-01-12

Family

ID=10835581

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010195A NO20010195L (no)	1998-07-15	2001-01-12	Fremgangsmåte for behandling

Country Status (20)

Country	Link
US (2)	US20020156093A1 (de)
EP (1)	EP1104301B1 (de)
JP (1)	JP2002520364A (de)
KR (1)	KR20010071893A (de)
CN (1)	CN1146420C (de)
AT (1)	ATE444751T1 (de)
AU (1)	AU758936B2 (de)
BR (1)	BR9912008A (de)
CA (1)	CA2337229A1 (de)
CZ (1)	CZ2001150A3 (de)
DE (1)	DE69941509D1 (de)
GB (1)	GB9815383D0 (de)
HU (1)	HUP0103149A3 (de)
IL (1)	IL140629A0 (de)
NO (1)	NO20010195L (de)
NZ (1)	NZ509177A (de)
PL (1)	PL345505A1 (de)
TR (1)	TR200100088T2 (de)
WO (1)	WO2000003717A1 (de)
ZA (1)	ZA200100360B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0008921D0 (en) *	2000-04-11	2000-05-31	Smithkline Beecham Plc	Method of treatment
KR100971395B1 (ko) *	2003-07-23	2010-07-21	엘지디스플레이 주식회사	백 라이트 유닛
JP4792726B2 (ja) *	2003-10-30	2011-10-12	日亜化学工業株式会社	半導体素子用支持体の製造方法
GB0428170D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Mono and Combination Therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG48315A1 (en) *	1989-04-13	1998-04-17	Beecham Group Plc	Novel compounds
GB9421472D0 (en) *	1994-10-25	1994-12-07	Smithkline Beecham Plc	Novel methods
GB9615628D0 (en) *	1996-07-25	1996-09-04	Smithkline Beecham Plc	Formulation
AU5716898A (en) *	1997-01-08	1998-08-03	Warner-Lambert Company	Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
JP2001520653A (ja)	1997-04-11	2001-10-30	エリリリーアンドカンパニー	精神分裂病の治療法

1998
- 1998-07-15 GB GBGB9815383.6A patent/GB9815383D0/en not_active Ceased
1999
- 1999-07-15 DE DE69941509T patent/DE69941509D1/de not_active Expired - Lifetime
- 1999-07-15 AT AT99937263T patent/ATE444751T1/de not_active IP Right Cessation
- 1999-07-15 HU HU0103149A patent/HUP0103149A3/hu unknown
- 1999-07-15 NZ NZ509177A patent/NZ509177A/en unknown
- 1999-07-15 EP EP99937263A patent/EP1104301B1/de not_active Expired - Lifetime
- 1999-07-15 BR BR9912008-9A patent/BR9912008A/pt not_active IP Right Cessation
- 1999-07-15 CZ CZ2001150A patent/CZ2001150A3/cs unknown
- 1999-07-15 TR TR2001/00088T patent/TR200100088T2/xx unknown
- 1999-07-15 JP JP2000559852A patent/JP2002520364A/ja not_active Withdrawn
- 1999-07-15 AU AU52137/99A patent/AU758936B2/en not_active Ceased
- 1999-07-15 KR KR1020017000561A patent/KR20010071893A/ko not_active Withdrawn
- 1999-07-15 CN CNB998086045A patent/CN1146420C/zh not_active Expired - Fee Related
- 1999-07-15 CA CA002337229A patent/CA2337229A1/en not_active Abandoned
- 1999-07-15 WO PCT/US1999/016002 patent/WO2000003717A1/en not_active Ceased
- 1999-07-15 PL PL99345505A patent/PL345505A1/xx not_active Application Discontinuation
- 1999-07-15 IL IL14062999A patent/IL140629A0/xx unknown
2001
- 2001-01-12 NO NO20010195A patent/NO20010195L/no not_active Application Discontinuation
- 2001-01-12 ZA ZA200100360A patent/ZA200100360B/en unknown
2002
- 2002-04-17 US US10/124,707 patent/US20020156093A1/en not_active Abandoned
2003
- 2003-02-21 US US10/372,577 patent/US6750227B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ZA200100360B (en)	2002-03-12
US20020156093A1 (en)	2002-10-24
CA2337229A1 (en)	2000-01-27
CZ2001150A3 (cs)	2001-09-12
NZ509177A (en)	2003-05-30
NO20010195D0 (no)	2001-01-12
AU5213799A (en)	2000-02-07
US6750227B2 (en)	2004-06-15
PL345505A1 (en)	2001-12-17
CN1309564A (zh)	2001-08-22
EP1104301A4 (de)	2004-09-15
EP1104301A1 (de)	2001-06-06
ATE444751T1 (de)	2009-10-15
GB9815383D0 (en)	1998-09-16
HUP0103149A2 (hu)	2002-01-28
EP1104301B1 (de)	2009-10-07
US20030125353A1 (en)	2003-07-03
IL140629A0 (en)	2002-02-10
WO2000003717A1 (en)	2000-01-27
TR200100088T2 (tr)	2001-06-21
CN1146420C (zh)	2004-04-21
DE69941509D1 (de)	2009-11-19
HUP0103149A3 (en)	2003-03-28
JP2002520364A (ja)	2002-07-09
KR20010071893A (ko)	2001-07-31
AU758936B2 (en)	2003-04-03
BR9912008A (pt)	2001-04-10

Similar Documents

Publication	Publication Date	Title
FI20000085L (fi)	2000-01-17	Menetelmä terapeuttisesti aktiivisten 4-amino-substituoitujen 2-azabicyklo/3.3.1/nonaanijohdannaisten valmistamiseksi
NZ332780A (en)	2000-07-28	Substituted amines for the treatment of neurological and neuropsychiatric disorders
MY130145A (en)	2007-06-29	Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
IL96398A0 (en)	1991-08-16	Therapeutically active chloro substituted benzimidazoles processes for their preparation as well as their use
HUP9904401A3 (en)	2001-03-28	Controlled release dosage form of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride
MY103352A (en)	1993-06-30	Piperazinyl-heterocyclic compounds
MXPA03009644A (es)	2004-01-29	Grupos azabiciclicos sustituidos para el tratamiento de enfermedades.
FI913510A0 (fi)	1991-07-22	Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi
UA41355C2 (uk)	2001-09-17	Засіб для лікування нейро-сніду
FI911083A7 (fi)	1991-09-07	Menetelmä kolinergisina aineina käyttökelpoisten 1-atsabisyklo/2.2.1/heptaani- tai -/2.2.2/oktaani-3-oni-O-oksiimien valmistamiseksi
HUP0101043A3 (en)	2002-02-28	Controlled release oral dosage form containing [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl]acetonitrile monohydrochlorid and process for its preparation
FI981709L (fi)	1998-08-06	Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi
NO20010195D0 (no)	2001-01-12	Fremgangsmåte for behandling
HUT71840A (en)	1996-02-28	Process for the preparation of azithromycin dihydrochloride
ZA914158B (en)	1993-03-01	Pharmacologically active CNS compounds.
CA2260863A1 (en)	1998-02-12	Treatment of psychotic disorders
DE69514315D1 (de)	2000-02-10	AZABICYCLOALKYLDERIVATE VON IMIDAZO[1,5-a]INDOL-3-ONE ALS 5HT3 ANTAGONISTEN
TR199900141T2 (xx)	1999-03-22	Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
EP0463712A3 (en)	1992-04-08	Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
EP0610669A3 (de)	1995-06-28	Vorrichtung zum Behandeln von Körperteilen mit Vibrationen.
ZA99740B (en)	1999-08-02	Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.
GB2262886B (en)	1995-09-06	N-channel calcium antagonists useful for treating bronchial diseases
HK1021336A (en)	2000-06-09	Controlled release dosage form of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride
FI890173L (fi)	1989-01-13	Isoxazoler med nootropisk verkan.
MX9202948A (es)	1993-04-01	Uso de atipamezol.

Legal Events

Date	Code	Title	Description
2006-02-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application